205 related articles for article (PubMed ID: 37247935)
1. Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors.
Chu J; Chung Y; Chae SW; Choi YJ; Kim HS; DO SI
Anticancer Res; 2023 Jun; 43(6):2707-2715. PubMed ID: 37247935
[TBL] [Abstract][Full Text] [Related]
2. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
[TBL] [Abstract][Full Text] [Related]
3. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
4. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
[TBL] [Abstract][Full Text] [Related]
5. Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer.
Wee E; Goh MS; Estall V; Tiong A; Webb A; Mitchell C; Murray W; Tran P; McCormack CJ; Henderson M; Hiscutt EL
Australas J Dermatol; 2018 Nov; 59(4):302-308. PubMed ID: 29349770
[TBL] [Abstract][Full Text] [Related]
6. Mohs micrographic surgery: a synopsis.
Stone JL
Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
Cumberland L; Dana A; Liegeois N
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
[TBL] [Abstract][Full Text] [Related]
8. An international survey characterizing Mohs tissue processing techniques and Mohs margin thresholds: how close is too close?
Hunt WTN; Nelson TG
Clin Exp Dermatol; 2022 Aug; 47(8):1472-1479. PubMed ID: 35279862
[TBL] [Abstract][Full Text] [Related]
9. [The role of the micrographic surgery in the management of basal cell carcinoma: experience in the Department of Dermatology, at the Hassan II University Hospital, Fes, Morocco].
Gallouj S; Aqil N; Harmouch T; Mernissi FZ
Pan Afr Med J; 2019; 33():245. PubMed ID: 31692779
[TBL] [Abstract][Full Text] [Related]
10. Indication guidelines for Mohs micrographic surgery in skin tumors.
Cernea SS; Gontijo G; Pimentel ER; Tarlé RG; Tassara G; Ferreira JA; Fernandes VM; Bernardo WM
An Bras Dermatol; 2016; 91(5):621-627. PubMed ID: 27828636
[TBL] [Abstract][Full Text] [Related]
11. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies.
Seth R; Revenaugh PC; Vidimos AT; Scharpf J; Somani AK; Fritz MA
Arch Facial Plast Surg; 2011; 13(6):404-10. PubMed ID: 22106186
[TBL] [Abstract][Full Text] [Related]
14. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
[TBL] [Abstract][Full Text] [Related]
15. Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors.
Mansilla-Polo M; Morgado-Carrasco D; Toll A
Actas Dermosifiliogr; 2024 Jun; 115(6):T555-T571. PubMed ID: 38648936
[TBL] [Abstract][Full Text] [Related]
16. Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors.
Mansilla-Polo M; Morgado-Carrasco D; Toll A
Actas Dermosifiliogr; 2024 Jun; 115(6):555-571. PubMed ID: 38395222
[TBL] [Abstract][Full Text] [Related]
17. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
18. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
19. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
20. Margin Reanalysis With 3-Dimensional Micrographic Surgery Technique of Conventional Excision Specimens With Negative Margin Readings.
Magliano J; Navarrete J; Lezue V; González A; Martínez M; Bazzano C
Am J Dermatopathol; 2021 Jul; 43(7):485-488. PubMed ID: 32956098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]